Standardized molecular analyses of glioma EVS

Ended Project Grant Awarded Last action

Award ID
R01CA237500
Recipient
Awarding agency
Obligated
$5,442,600

Award facts

Assistance listing
93.394 Cancer Detection and Diagnosis Research
Completion date
Originally
Funding
  • $4,817,686.00 Federal
  • $624,914.00 Non-federal
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $0 $0
Amendment $557,524 $0
Amendment $577,860 $0
Amendment $577,860 $0
Amendment $602,790 $0
Amendment $602,790 $0
Amendment $624,914 $0
Amendment Standardized molecular analyses of glioma EVS - extracellular vesicles (EVS) have emerged as a promising surrogate for tissue biopsy, potentially enabling… $624,914 $624,914
Original award $649,034 $0

Subawards

Subrecipient Amount Awarded
Exosome Diagnostics Inc. The main objective of this collaborative proposal is to optimize assays and technology to purify and characterize cancer specific extracellular vesicles,… $136,037

Quick answers

Who received award R01CA237500?

R01CA237500 was awarded to The General Hospital Corporation by National Cancer Institute (National Institutes of Health) on July 1, 2020.

How much is award R01CA237500 worth?

$5,442,600 has been obligated on R01CA237500: $4,817,686 in federal funding and $624,914 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login